Growth Metrics

Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026)

Verastem's quarterly Shares Outstanding (Weighted Average) came in at $98.3 million in Q1 2026, up 81.44% year-on-year from $54.2 million in Q1 2025, and up 1066.09% quarter-over-quarter from $8.4 million in Q4 2025.

Verastem has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $98.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 81.44% year-over-year to $98.3 million; the trailing twelve-month figure through Mar 2026 stood at $98.3 million (up 81.44% YoY), and the FY2025 full-year result was $8.4 million, down 53.39% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $98.3 million, up from $8.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $186.3 million in Q1 2022, with the low at $8.4 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $41.5 million, with a median of $22.1 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Weighted Average) tumbled 91.02% in 2023 and surged 146.38% in 2025.
  • Tracing VSTM's Shares Outstanding (Weighted Average) over 5 years: stood at $16.1 million in 2022, then soared by 36.66% to $22.1 million in 2023, then declined by 18.0% to $18.1 million in 2024, then plunged by 53.39% to $8.4 million in 2025, then jumped by 1066.09% to $98.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $98.3 million (Q1 2026), $8.4 million (Q4 2025), and $64.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 177,333.76 Bn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 185,491.37 Bn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 55.66 Bn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 132.89 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 98.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.29 Mn
Dec 31, 2025 8.43 Mn
Sep 30, 2025 64.56 Mn
Jun 30, 2025 66.14 Mn
Mar 31, 2025 54.17 Mn
Dec 31, 2024 18.08 Mn
Sep 30, 2024 31.35 Mn
Jun 30, 2024 26.85 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 22.05 Mn
Sep 30, 2023 20.45 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 16.72 Mn
Dec 31, 2022 16.14 Mn
Sep 30, 2022 16.43 Mn
Jun 30, 2022 15.53 Mn
Mar 31, 2022 186.26 Mn
Dec 31, 2021 14.54 Mn
Sep 30, 2021 179.86 Mn
Jun 30, 2021 171.99 Mn
Mar 31, 2021 171.59 Mn
Dec 31, 2020 153.33 Mn
Sep 30, 2020 169.51 Mn
Jun 30, 2020 165.40 Mn
Mar 31, 2020 108.15 Mn
Dec 31, 2019 74.58 Mn
Sep 30, 2019 74.23 Mn
Jun 30, 2019 73.88 Mn
Mar 31, 2019 73.85 Mn
Dec 31, 2018 64.96 Mn
Sep 30, 2018 73.64 Mn
Jun 30, 2018 61.26 Mn
Mar 31, 2018 50.84 Mn
Dec 31, 2017 38.42 Mn
Sep 30, 2017 37.21 Mn
Jun 30, 2017 36.99 Mn
Mar 31, 2017 36.99 Mn
Dec 31, 2016 36.99 Mn
Sep 30, 2016 36.99 Mn
Jun 30, 2016 36.99 Mn
Mar 31, 2016 36.98 Mn
Dec 31, 2015 35.93 Mn
Sep 30, 2015 36.90 Mn
Jun 30, 2015 36.52 Mn
Mar 31, 2015 33.32 Mn
Dec 31, 2014 25.80 Mn
Sep 30, 2014 25.81 Mn
Jun 30, 2014 25.67 Mn
Mar 31, 2014 25.48 Mn
Dec 31, 2013 22.68 Mn
Sep 30, 2013 24.13 Mn
Jun 30, 2013 20.73 Mn
Mar 31, 2013 20.48 Mn
Dec 31, 2012 18.77 Mn
Sep 30, 2012 20.16 Mn
Jun 30, 2012 19.86 Mn
Mar 31, 2012 14.69 Mn
Dec 31, 2011 1.30 Mn
Sep 30, 2011 1.36 Mn
Jun 30, 2011 1.23 Mn
Mar 31, 2011 1.09 Mn